Japan Cell Therapy Market Size, Share, Industry, Forecast and Outlook (2024-2031)

<h2>Japan Cell Therapy Market is segmented By Product Type (Equipment, Software, Consumables) By Process (Cell Processing, Cell Preservation, Distribution, and Handling, Process Monitoring and Quality Control) By Application (Oncology, Autoimmune Diseases, Infectious Diseases, Urinary Disorders, Others) By End User (Hospitals, Clinics, Others)&nbsp;&ndash; Share, Size, Outlook, and Opportunity Analysis, 2024-2031</h2>

<h3>Market Overview</h3>

<blockquote>
<p>Japan Cell Therapy Market reached US$ YY&nbsp;million in 2023 and is expected to reach US$ YY&nbsp;million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031</p>
</blockquote>

<p>The Japan market for cell therapy is constantly growing to include new cell types, which presents significant opportunities for companies to strengthen their market positions. As a result, during the past few years, there has been a dramatic increase in the number of companies engaged in developing cell therapies.</p>

<h3>Market&nbsp;Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			<p><strong>Metrics</strong></p>
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			<p><strong>Details</strong></p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			<p><strong>CAGR</strong></p>
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			<p>YY%</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Market Size Available for Years</strong></p>
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>2022-2031</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Estimation Forecast Period</strong></p>
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>2024-2031</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Revenue Units</strong></p>
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>Value (US$ Mn)&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Segments Covered</strong></p>
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>Product Type, Process, Application, End User</p>
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p><strong>Report Insights Covered</strong></p>
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			<p>Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.</p>
			</td>
		</tr>
	</tbody>
</table>

<p><br />
<strong>For more details on this report</strong> &ndash; <a href="https://www.datamintelligence.com/download-sample/japan-cell-therapy-market" target="_blank">Request for Sample</a><br />
&nbsp;</p>

<h3>Market Dynamics: Drivers &amp; Restraints</h3>

<p><strong>Rise in the prevalence of cancers in Japan</strong></p>

<p>CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them to locate in destroy cancer cells more effectively. In Japan, cancer has been the leading cause of death since 1981, accounting for one-third of total deaths in this developed country with a high life expectancy.&nbsp;</p>

<p>According to the National Cancer Center of Japan, there were estimations of 1,019,000 new cancer cases and 380,400 cancer deaths in 2022. The most common cancers in Japan include colorectal, stomach, lung, prostate, and female breast cancers, which account for approximately 60% of all cancer cases in the country.</p>

<p>Furthermore, Japan cell therapy is also driven by various other factors like a rise in the advancements in the equipment, novel product launches by key players and others helping the market to grow during the forecast period.</p>

<p><strong>Dearth of skilled professionals</strong></p>

<p>Despite technological advancements and product development over the last decade, the market has been hampered by a shortage of skilled workers who can operate sophisticated instruments like flow cytometers and multi-mode readers. Flow cytometers and spectrophotometers, which are technologically modern and very complicated, produce a wide range of data outputs that require skill to analyse and review. There remains, nevertheless, a global demand-supply gap for trained people.</p>

<h3>Segment Analysis</h3>

<p>The Japan cell therapy market is segmented based on product type, process, application, end-user and region.</p>

<p><strong>The equipment from the product type segment accounted for approximately 41.7 % of the Japan cell therapy&nbsp; market share</strong></p>

<p>The equipment from the product type segment accounted for approximately 41.7%. Cell therapy involves the use of various equipment, including biosafety cabinets, incubators, refrigerators, freezers, centrifuges, bioreactors, microscopes, and cell counters. These cabinets provide a controlled environment for working with materials that require specific protection. Incubators maintain optimal conditions for cell growth and proliferation.&nbsp;</p>

<p>Refrigerators store materials at specific temperatures, while freezers store cells, tissues, and biological samples for long-term storage. Centrifuges separate components based on density. Other equipment like bioreactors, microscopes, and cell counters are also commonly used. Companies like Corning provide specialised equipment for cell and gene therapy applications that meet FDA standards.</p>

<p>For instance, in February 2022, Takara Bio Inc. opened an expansion of its manufacturing facility, the Center for Gene and Cell Processing (CGCP), at the company&rsquo;s headquarters in Shiga, Japan. The expansion of the facility, which went into operation in 2020, features increased production capacity. New equipment includes 200 L bioreactors, 2,000 L fermenters, and large flow centrifuge and purification systems.</p>

<h3>Covid 19 Impact Analysis</h3>

<p>The impact of COVID-19 on cell therapy in Japan has been significant, affecting various aspects of healthcare and treatment. Studies have shown that the pandemic has disrupted the cell and gene therapy industry globally, including Japan. Specifically, the pandemic has influenced allogeneic stem cell transplantation in Japan, affecting healthcare quality and access for patients undergoing these procedures.</p>

<h3>Competitive Landscape</h3>

<p>The major global players in the market include Fresenius Kabi, Thermo Fisher Scientific, Inc., Terumo Corporation, Stemcell Technologies, Sartorius, Aurion Biotech, Novartis AG, JCR Pharmaceuticals Co., Ltd, Johnson &amp; Johnson Services, Inc. and among others.</p>

<h3>Key Developments</h3>

<ul>
	<li>In March 2023, Aurion Biotech announced it has received regulatory approval from Japan&rsquo;s Pharmaceuticals and Medical Devices Agency (PMDA) for its novel cell therapy Vyznova for the treatment of bullous keratopathy of the cornea.</li>
</ul>

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the Japan cell therapy market segmentation based on product type, process, application, end-user and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analysing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of Japan cell therapy market level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

<p><strong><em>The Japan cell therapy market report would provide approximately 64 tables, 61 figures and 186 pages.</em></strong></p>

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>


<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Product Type</li>
		<li>Snippet by Process&nbsp;</li>
		<li>Snipper by Application</li>
		<li>Snippet by End User</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Rise in the prevalence of cancers in the country</li>
				<li>Rise in advancements of equipment&rsquo;s</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>Dearth of skilled professionals</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Patent Analysis</li>
		<li>PESTLE Analysis</li>
		<li>SWOT Analysis</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Product Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type</li>
			<li>Market Attractiveness Index, By Product Type</li>
		</ol>
		</li>
		<li>Equipment*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Software</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Consumables</h3>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#000000; font-style:normal">By Process</h3>

	<ol>
		<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Process&nbsp;</li>
		<li>Market Attractiveness Index, By Process</li>
	</ol>

	<ol>
		<li>Cell Processing*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>
		<h3 style="color:#000000; font-style:normal">Cell Preservation, Distribution, and Handling</h3>
		</li>
		<li>
		<h3 style="color:#000000; font-style:normal">Process Monitoring and Quality Control</h3>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#000000; font-style:normal">By Application</h3>

	<ol>
		<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application&nbsp;</li>
		<li>Market Attractiveness Index, By Application</li>
	</ol>

	<ol>
		<li>Oncology*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Autoimmune Diseases</li>
		<li>Infectious Diseases</li>
		<li>Urinary Disorders</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End User</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Attractiveness Index, By End User</li>
		</ol>
		</li>
		<li>Hospitals*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Clinics</h3>
		</li>
		<li>
		<h3 style="color:#1f3863; font-style:normal">Others</h3>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Fresenius Kabi*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Thermo Fisher Scientific, Inc.</li>
		<li>Terumo Corporation</li>
		<li>Stemcell Technologies</li>
		<li>Sartorius</li>
		<li>Aurion Biotech</li>
		<li>Novartis AG</li>
		<li>JCR Pharmaceuticals Co., Ltd</li>
		<li>Johnson &amp; Johnson Services, Inc &nbsp;(<em>LIST NOT EXHAUSTIVE)&nbsp;</em></li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>


<p><strong>List of Tables</strong></p>

<p>Table 1 Japan Cell Therapy Market Value, By Product Type, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 2 Japan Cell Therapy Market Value, By Process, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 3 Japan Cell Therapy Market Value, By Application, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 4 Japan Cell Therapy Market Value, By End User, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 5 Japan Cell Therapy Market Value, By Product Type, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 6 Japan Cell Therapy Market Value, By Product Type, 2022-2031(US$ Million)</p>

<p>Table 7 Japan Cell Therapy Market Value, By Process, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 8 Japan Cell Therapy Market Value, By Process, 2022-2031(US$ Million)</p>

<p>Table 9 Japan Cell Therapy Market Value, By Application, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 10 Japan Cell Therapy Market Value, By Application, 2022-2031(US$ Million)</p>

<p>Table 11 Japan Cell Therapy Market Value, By End User, 2023, 2027 &amp; 2031 (US$ Million)</p>

<p>Table 12 Japan Cell Therapy Market Value, By End User, 2022-2031(US$ Million)</p>

<p>Table 13 Fresenius Kabi: Overview</p>

<p>Table 14 Fresenius Kabi: Product Portfolio</p>

<p>Table 15 Fresenius Kabi: Key Developments</p>

<p>Table 16 Thermo Fisher Scientific, Inc.: Overview</p>

<p>Table 17 Thermo Fisher Scientific, Inc.: Product Portfolio</p>

<p>Table 18 Thermo Fisher Scientific, Inc.: Key Developments</p>

<p>Table 19 Terumo Corporation: Overview</p>

<p>Table 20 Terumo Corporation: Product Portfolio</p>

<p>Table 21 Terumo Corporation: Key Developments</p>

<p>Table 22 Stemcell Technologies: Overview</p>

<p>Table 23 Stemcell Technologies: Product Portfolio</p>

<p>Table 24 Stemcell Technologies: Key Developments</p>

<p>Table 25 Sartorius: Overview</p>

<p>Table 26 Sartorius: Product Portfolio</p>

<p>Table 27 Sartorius: Key Developments</p>

<p>Table 28 Aurion Biotech: Overview</p>

<p>Table 29 Aurion Biotech: Product Portfolio</p>

<p>Table 30 Aurion Biotech: Key Developments</p>

<p>Table 31 Novartis AG: Overview</p>

<p>Table 32 Novartis AG: Product Portfolio</p>

<p>Table 33 Novartis AG: Key Developments</p>

<p>Table 34 JCR Pharmaceuticals Co., Ltd: Overview</p>

<p>Table 35 JCR Pharmaceuticals Co., Ltd: Product Portfolio</p>

<p>Table 36 JCR Pharmaceuticals Co., Ltd: Key Developments</p>

<p>Table 37 Johnson &amp; Johnson Services, Inc: Overview</p>

<p>Table 38 Johnson &amp; Johnson Services, Inc: Product Portfolio</p>

<p>Table 39 Johnson &amp; Johnson Services, Inc: Key Developments</p>

<p><strong>List of Figures</strong></p>

<p>Figure 1 Japan Cell Therapy Market Value, 2022-2031(US$ Million)</p>

<p>Figure 2 Japan Cell Therapy Market Share, By Product Type, 2022 &amp; 2031(%)</p>

<p>Figure 3 Japan Cell Therapy Market Share, By Process, 2022 &amp; 2031(%)</p>

<p>Figure 4 Japan Cell Therapy Market Share, By Application, 2022 &amp; 2031(%)</p>

<p>Figure 5 Japan Cell Therapy Market Share, By End User, 2022 &amp; 2031(%)</p>

<p>Figure 6 Japan Cell Therapy Market Y-o-Y Growth, By Product Type, 2022-2031(%)</p>

<p>Figure 7 Equipment Japan Cell Therapy Market Value, 2022-2031(US$ Million)</p>

<p>Figure 8 Software Japan Cell Therapy Market Value, 2022-2031(US$ Million)</p>

<p>Figure 9 Consumables Japan Cell Therapy Market Value, 2022-2031(US$ Million)</p>

<p>Figure 10 Japan Cell Therapy Market Y-o-Y Growth, By Process, 2022-2031(%)</p>

<p>Figure 11 Cell Processing Process in Japan Cell Therapy Market Value, 2022-2031(US$ Million)</p>

<p>Figure 12 Cell Preservation, Distribution, and Handling Process in Japan Cell Therapy Market Value, 2022-2031(US$ Million)</p>

<p>Figure 13 Process Monitoring and Quality Control Process in Japan Cell Therapy Market Value, 2022-2031(US$ Million)</p>

<p>Figure 14 Japan Cell Therapy Market Y-o-Y Growth, By Application, 2022-2031(%)</p>

<p>Figure 15 Oncology Application in Japan Cell Therapy Market Value, 2022-2031(US$ Million)</p>

<p>Figure 16 Autoimmune Diseases Application in Japan Cell Therapy Market Value, 2022-2031(US$ Million)</p>

<p>Figure 17 Infectious Diseases Application in Japan Cell Therapy Market Value, 2022-2031(US$ Million)</p>

<p>Figure 18 Urinary Disorders Application in Japan Cell Therapy Market Value, 2022-2031(US$ Million)</p>

<p>Figure 19 Others Application in Japan Cell Therapy Market Value, 2022-2031(US$ Million)</p>

<p>Figure 20 Japan Cell Therapy Market Y-o-Y Growth, By End User, 2022-2031(%)</p>

<p>Figure 21 Hospitals End User in Japan Cell Therapy Market Value, 2022-2031(US$ Million)</p>

<p>Figure 22 Clinics End User in Japan Cell Therapy Market Value, 2022-2031(US$ Million)</p>

<p>Figure 23 Others End User in Japan Cell Therapy Market Value, 2022-2031(US$ Million)</p>

<p>Figure 24 Fresenius Kabi: Financials</p>

<p>Figure 25 Thermo Fisher Scientific, Inc.: Financials</p>

<p>Figure 26 Terumo Corporation: Financials</p>

<p>Figure 27 Stemcell Technologies: Financials</p>

<p>Figure 28 Sartorius: Financials</p>

<p>Figure 29 Aurion Biotech: Financials</p>

<p>Figure 30 Novartis AG: Financials</p>

<p>Figure 31 JCR Pharmaceuticals Co., Ltd: Financials</p>

<p>Figure 32 Johnson &amp; Johnson Services, Inc: Financials</p>


Japan Cell Therapy Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Oncology Therapy Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 March 28

Starting from

Cell Therapy Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 11

Starting from